EFSA CEF Panel (EFSA Panel on Food Contact Materials, Enzymes, Flavourings and Processing Aids), 2013. Scientific Opinion on Flavouring Group Evaluation 220, Revision 2 (FGE.220Rev1): α,β-Unsaturated ketones and precursors from chemical subgroup 4.4 of FGE.19: 3(2H)-Furanones by 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
General rights 
Copyright and moral rights for the publications made accessible in the public portal are retained by the authors and/or other copyright owners 
and it is a condition of accessing publications that users recognise and abide by the legal requirements associated with these rights. 
 
• Users may download and print one copy of any publication from the public portal for the purpose of private study or research. 
• You may not further distribute the material or use it for any profit-making activity or commercial gain 
• You may freely distribute the URL identifying the publication in the public portal  
 
If you believe that this document breaches copyright please contact us providing details, and we will remove access to the work immediately 
and investigate your claim. 
   
 
Downloaded from orbit.dtu.dk on: Dec 19, 2017
EFSA CEF Panel (EFSA Panel on Food Contact Materials, Enzymes, Flavourings and
Processing Aids), 2013. Scientific Opinion on Flavouring Group Evaluation 220,
Revision 2 (FGE.220Rev1): ,-Unsaturated ketones and precursors from chemical
subgroup 4.4 of FGE.19: 3(2H)-Furanones
EFSA publication; Beltoft, Vibe Meister; Binderup, Mona-Lise; Lund, Pia; Nørby, Karin Kristiane
Link to article, DOI:
10.2903/j.efsa.2013.3390
Publication date:
2013
Document Version
Publisher's PDF, also known as Version of record
Link back to DTU Orbit
Citation (APA):
EFSA publication (2013). EFSA CEF Panel (EFSA Panel on Food Contact Materials, Enzymes, Flavourings and
Processing Aids), 2013. Scientific Opinion on Flavouring Group Evaluation 220, Revision 2 (FGE.220Rev1): ,-
Unsaturated ketones and precursors from chemical subgroup 4.4 of FGE.19: 3(2H)-Furanones. Parma, Italy:
European Food Safety Authority.  (The EFSA Journal; No. 3390, Vol. 11(10)). DOI: 10.2903/j.efsa.2013.3390
  EFSA Journal 2013;11(10):3390 
 
Suggested citation: EFSA CEF Panel (EFSA Panel on Food Contact Materials, Enzymes, Flavourings and Processing Aids), 
2013. Scientific Opinion on Flavouring Group Evaluation 220, Revision 2 (FGE.220Rev1): α,β-Unsaturated ketones and 
precursors from chemical subgroup 4.4 of FGE.19: 3(2H)-Furanones. EFSA Journal 2013;11(10):3390, 30 pp. 
doi:10.2903/j.efsa.2013.3390 
Available online: www.efsa.europa.eu/efsajournal  
© European Food Safety Authority, 2013 
SCIENTIFIC OPINION 
Scientific Opinion on Flavouring Group Evaluation 220, Revision 2 
(FGE.220Rev1): α,β-Unsaturated ketones and precursors from chemical 
subgroup 4.4 of FGE.19: 3(2H)-Furanones
1
 
EFSA Panel on Food Contact Materials, Enzymes, Flavourings and Processing Aids 
(CEF)
2, 3
 
European Food Safety Authority (EFSA), Parma, Italy 
 
ABSTRACT 
The Panel on Food Contact Materials, Enzymes, Flavourings and Processing Aids of the European Food Safety 
Authority was requested to evaluate the genotoxic potential of 10 flavouring substances from subgroup 4.4 of 
FGE.19 in the Flavouring Group Evaluation 220 (FGE.220). FGE.220 is subdivided into two subgroups 
(subgroup 4.4a containing [FL-no: 13.089, 13.117, 13.119, 13.157 and 13.175] and subgroup 4.4b containing 
[13.010, 13.084 and 13.085, 13.099 and 13.176]. For both subgroups the Panel concluded that the genotoxicity 
alert could not be ruled out based on the data available and accordingly additional genotoxicity data were 
requested. In FGE.220, Revision 1, the Panel concluded, based on new submitted data, that for the substances in 
subgroup 4.4b there is no concern for genotoxicity. The Flavour Industry has now provided additional 
genotoxicity studies for two representative substances of subgroup 4.4a, 2,5-dimethylfuran-3(2H)-one [FL-no: 
13.119] and 4-acetyl-2,5-dimethylfuran-3(2H)-one [FL-no: 13.175]. Based on the new data the Panel concluded 
that 2,5-dimethylfuran-3(2H)-one [FL-no: 13.119] does not give rise to concern with respect to genotoxicity. For 
4-acetyl-2,5-dimethylfuran-3(2H)-one [FL-no: 13.175] the concern for genotoxicity could not be ruled out and 
therefore the Panel requests a repetition of the submitted micronucleus study in the presence of S9-mix applying 
the same conditions and possibly in addition modified conditions, or a combined in vivo micronucleus and 
Comet assay, including analysis of liver. This is also applicable to 2,5-dimethyl-4-methoxyfuran-3(2H)-one [FL-
no:13.089] and 2,5-dimethyl-4-ethoxyfuran-3(2H)-one [FL-no:13.117], which are covered by the representative 
substance 4-acetyl-2,5-dimethylfuran-3(2H)-one [FL-no:13.175]. The Flavour Industry has informed that 5-
methylfuran-3(2H)-one [FL-no: 13.157] is not in common use in the flavour industry and is no longer supported.  
© European Food Safety Authority, 2013 
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3  Acknowledgement: The Panel wishes to thank : Mona-Lise Binderup, Claudia Bolognesi, Wilfried Bursch, Angelo Carere, 
Riccardo Crebelli, Rainer Gürtler, Daniel Marzin, Pasquale Mosesso for the preparatory work on this scientific opinion and 
the hearing experts: Vibe Beltoft, Pia Lund, Karin Nørby and EFSA staff: Maria Carfi, Annamaria Rossi and Kim Rygaard 
Nielsen for the support provided to this scientific opinion.  
Flavouring Group Evaluation 220 Revision 2 
 
EFSA Journal 2013;11(10):3390 2 
KEY WORDS 
alpha,beta-unsaturated ketones, 3(2H)-furanones, flavouring substances, safety evaluation 
SUMMARY 
Following a request from European Commission, the EFSA Panel on Food Contact Materials, 
Enzymes, Flavourings and Processing Aids (CEF) was asked to deliver a scientific opinion on the 
implications for human health of chemically defined flavouring substances used in or on foodstuffs in 
the Member States. In particular, the Panel was asked to evaluate 10 flavouring substances in 
Flavouring Group Evaluation 220 (FGE.220) using the Procedure as referred to in the Commission 
Regulation (EC) No 1565/2000.  
Flavouring Group Evaluation 220 (FGE.220) concerned 10 substances, corresponding to subgroup 4.4 
of FGE.19. The 10 substances are α,β-unsaturated 3(2H)-furanones [FL-no: 13.010, 13.084, 13.085, 
13.089, 13.099, 13.117, 13.119, 13.157, 13.175 and 13.176]. The substances were further subdivided 
into two subgroups as five [FL-no: 13.089, 13.117, 13.119, 13.157 and 13.175] of the 10 substances 
can only exist as α,β-unsaturated ketones (subgroup 4.4a) while in the other five substances [13.010, 
13.084 and 13.085, 13.099 and 13.176], the α,β double bond can be involved in keto-enol tautomerism 
(subgroup 4.4b). 
For both groups the Panel concluded that the genotoxicity alert could not be ruled out based on data 
available at that time, and accordingly additional genotoxicity data were requested for both groups. 
The additional information should be based on specific data requested in FGE.220 and performed on 
representative substances selected from both groups.  
Revision 1 of FGE.220 (FGE.220Rev1) concerned the evaluation of additional data submitted by 
Industry in response to the requested genotoxicity data in FGE.220 on the representative substance for 
subgroup 4.4b, 4-hydroxy-2,5-dimethylfuran-3(2H)-one [FL-no: 13.010]. The Panel concluded that for 
the substances [13.010, 13.084 and 13.085, 13.099 and 13.176] in subgroup 4.4b there is no concern 
for genotoxicity, and these substances were accordingly evaluated through the Procedure in FGE.99.  
The present revision of FGE.220 (FGE.220Rev2), concerns the evaluation of additional data submitted 
by Industry in response to requested genotoxicity data in FGE.220 on representative substances for 
subgroup 4.4a. The Flavour Industry has informed that one of the representative substances, 5-
methylfuran-3(2H)-one [FL-no: 13.157], is not in common use in the flavour industry and is no longer 
supported. As an alternative substance for testing within this subgroup, the Flavour Industry had 
proposed the structurally related substance 2,5-dimethylfuran-3(2H)-one [FL-no: 13.119]. 
Accordingly, additional genotoxicity data have now been submitted for 2,5-dimethylfuran-3(2H)-one 
[FL-no: 13.119] and 4-acetyl-2,5-dimethylfuran-3(2H)-one [FL-no: 13.175]. 
These data have been examined by the Panel which concluded that 2,5-dimethylfuran-3(2H)-one [FL-
no: 13.119] does not give rise to concern with respect to genotoxicity and can accordingly be 
evaluated using the Procedure. For 4-acetyl-2,5-dimethylfuran-3(2H)-one [FL-no: 13.175] the concern 
for genotoxicity could not be ruled out and therefore the Panel requests a repetition of the submitted 
micronucleus study in the presence of S9-mix applying the same conditions and possibly in addition 
modified conditions, or a combined in vivo micronucleus and Comet assay, including analysis of liver. 
This is also applicable to 2,5-dimethyl-4-methoxyfuran-3(2H)-one [FL-no:13.089] and 2,5-dimethyl-
4-ethoxyfuran-3(2H)-one [FL-no:13.117] which are covered by the representative substance 4-acetyl-
2,5-dimethylfuran-3(2H)-one [FL-no:13.175]. 
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BACKGROUND AS PROVIDED BY THE EUROPEAN COMMISSION 
The use of flavouring is regulated under Regulation (EC) No 1334/2008
4
 of the European Parliament 
and Council of 16 December 2008 on flavourings and certain food ingredients with flavouring 
properties for use in and on foods. On the basis of article 9(a) of this Regulation an evaluation and 
approval are required for flavouring substances. 
The Union List of flavourings and source materials was established by Commission Implementing 
Regulation (EC) No 872/2012
5
. The list contains flavouring substances for which the scientific 
evaluation should be completed in accordance with Commission Regulation (EC) No 1565/2000
6
. 
EFSA concluded that a genotoxic potential of five 3(2H)-furanones, corresponding to subgroup 4.4a 
of FGE.19 in the present FGE.220, could not be ruled out. 
Information on two representative materials has now been submitted by the European Flavour 
Association. These are 2,5-dimethylfuran-3(2H)-one [FL-no: 13.119] and 4-acetyl-2,5-dimethylfuran-
3(2H)-one [FL-no: 13.175]. This information is intended to cover the re-evaluation of these two 
substances and of two substances from FGE.19 subgroup 4.4a: 2,5-dimethyl-4-methoxyfuran-3(2H)-
one [FL-no: 13.089] and 2,5-dimethyl-4-ethoxyfuran-3(2H)-one [FL-no: 13.117]. 
The commission asks EFSA to evaluate this new information and depending on the outcome proceed 
to the full evaluation of the flavouring substances. 
TERMS OF REFERENCE AS PROVIDED BY THE EUROPEAN COMMISSION 
The European Commission requests the European Food Safety Authority to carry out a safety 
assessment on the following four flavouring substances: 2,5-dimethyl-4-methoxyfuran-3(2H)-one 
[FL-no: 13.089], 2,5-dimethyl-4-ethoxyfuran-3(2H)-one [FL-no: 13.117], 2,5-dimethylfuran-3(2H)-
one [FL-no: 13.119] and 4-acetyl-2,5-dimethylfuran-3(2H)-one [FL-no: 13.175] in accordance with 
Commission Regulation (EC) No 1565/2000. 
HISTORY OF FGE.19 
Flavouring Group Evaluation 19 (FGE.19) contains 360 flavouring substances from the EU Register 
being α,β-unsaturated aldehydes or ketones and precursors which could give rise to such carbonyl 
substances via hydrolysis and/or oxidation (EFSA, 2008a). 
The α,β-unsaturated aldehyde and ketone structures are structural alerts for genotoxicity. The Panel 
noted that there were limited genotoxicity data on these flavouring substances but that positive 
genotoxicity studies were identified for some substances in the group. 
The α,β-unsaturated carbonyls were subdivided into subgroups on the basis of structural similarity 
(EFSA, 2008a). In an attempt to decide which of the substances could go through the Procedure, a 
                                                     
4  Regulation (EC) No 1334/2008 of the European Parliament and of the Council of 16 December 2008 on flavourings and 
  certain food ingredients with flavouring properties for use in and on foods and amending Council Regulation (EEC) No 
 1601/91, Regulations (EC) No 2232/96 and (EC) No 110/2008 and Directive 2000/13/EC. Official Journal of the European 
 Communities 31.12.2008, L 354/34-50. 
 
5  EC (European Commission), 2012. Commission implementing Regulation (EU) No 872/2012 of 1 October 2012 adopting 
 the list of flavouring substances provided for by Regulation (EC) No 2232/96 of the European Parliament and of the 
 Council, introducing it in Annex I to Regulation (EC) No 1334/2008 of the European Parliament and of the Council and 
 repealing Commission Regulation (EC) No 1565/2000 and Commission Decision 1999/217/EC. Official Journal of the 
 European Communities 2.10.2012, L 267, 1-161.OJ L 267, 2.10.2012, p. 1. 
 
6  Commission Regulation No 1565/2000 of 18 July 2000 laying down the measures necessary for the adoption of an 
 evaluation programme in application of Regulation (EC) No 2232/96. Official Journal of the European Communities 
 19.7.2000, L 180, 8-16. 
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(quantitative) structure-activity relationship (Q)SAR prediction of the genotoxicity of these substances 
was undertaken considering a number of models (DEREKfW, TOPKAT, DTU-NFI-MultiCASE 
Models and ISS-Local Models, (Gry et al., 2007)). 
The Panel noted that for most of these models internal and external validation has been performed, but 
considered that the outcome of these validations was not always extensive enough to appreciate the 
validity of the predictions of these models for these α,β-unsaturated carbonyls. Therefore, the Panel 
considered it inappropriate to totally rely on (Q)SAR predictions at this point in time and decided not 
to take substances through the Procedure based on negative (Q)SAR predictions only. 
The Panel took note of the (Q)SAR predictions by using two ISS Local Models (Benigni and Netzeva, 
2007a; Benigni and Netzeva, 2007b) and four DTU-NFI MultiCASE Models (Gry et al., 2007; 
Nikolov et al., 2007) and the fact that there are available data on genotoxicity in vitro and in vivo, as 
well as data on carcinogenicity for several substances. The Panel decided that 11 subgroups (1.1.2, 
1.1.3, 1.1.4, 2.4, 2.6, 2.7, 3.1, 3.3, 4.1, 4.2 and 4.4) of FGE.19 (EFSA, 2008a) should be further 
examined to determine whether evaluation through the Procedure is feasible. Corresponding to these 
11 subgroups, 11 Flavouring Group Evaluations (FGEs) were established (FGE.201, 202, 203, 210, 
212, 213, 214, 216, 217, 218 and 220). If the Panel concludes for any substances in these 11 FGEs that 
they cannot be evaluated using the Procedure then it has to be decided if there is a safety concern for 
certain substances or if additional data are required in order to finalise the evaluation. If the Panel 
concludes that a genotoxic potential can be ruled out for the substances, they will be merged with 
structurally related substances in other FGEs and evaluated using the Procedure. 
To ease the data retrieval of the large number of structurally related α,β-unsaturated substances in the 
different subgroups for which additional data are requested, EFSA has worked out a list of 
representative substances for each subgroup (EFSA, 2008c). Likewise, an EFSA genotoxicity expert 
group has worked out a test strategy to be followed in the data retrieval for these substances (EFSA, 
2008b).  
The Flavouring Industry has been requested to submit additional genotoxicity data according to the list 
of representative substances and test strategy for each subgroup.  
The Flavouring Industry has now submitted additional data and the present revision of FGE.216 
concerns the evaluation of these data requested on genotoxicity. 
ASSESSMENT 
1. History of the Evaluation of the Substances in the present FGE 
EFSA considered in FGE.220 subgroup 4.4 of FGE.19 (EFSA, 2008a). Subgroup 4.4 consists of 10 
α,β-unsaturated 3(2H)-furanones, which have been further subdivided into two groups 4.4a and 4.4b 
based on chemical structures (Table 2). For both groups the Panel concluded that the genotoxicity alert 
could not be ruled out based on data available at that time, and accordingly additional genotoxicity 
data were requested for both groups. The additional information should be based on specific data 
requested in FGE.220 and performed on representative substances selected from both groups (EFSA, 
2008c).  
In the EFSA Opinion “List of α,β-unsaturated aldehydes and ketones representative of FGE.19 
substances for genotoxicity testing” (EFSA, 2008c), representative flavouring substances have been 
selected for subgroups 4.4a and 4.4b, corresponding to FGE.220, for which additional data on 
genotoxicity were requested, according to the Opinion of the Panel on the Genotoxicity Test Strategy 
for Substances Belonging to Subgroups of FGE.19” (EFSA, 2008b). 
Revision 1 of FGE.220 (FGE.220Rev1) concerned the evaluation of additional data submitted by 
Industry in response to the requested genotoxicity data in FGE.220 on the representative substance for 
subgroup 4.4b, 4-hydroxy-2,5-dimethylfuran-3(2H)-one [FL-no: 13.010]. The description and 
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evaluation of these data are cited from FGE.220Rev1 in Section 5 in the present Revision 2 of 
FGE.220 (FGE.220Rev2).  
FGE Adopted by 
EFSA 
Link No. of 
Substances 
FGE.220 29 january 2009 http://www.efsa.europa.eu/EFSA/efsa_locale-
1178620753812_1211902503180.htm 
10 
FGE.220Rev1 30 September 
2010 
http://www.efsa.europa.eu/en/efsajournal/pub/1841.htm 10 
FGE.220Rev2   9 
 
The present Revision 2 of FGE.220 (FGE.220Rev2), concerns the evaluation of additional data 
submitted by Industry in response to requested genotoxicity data in FGE.220 on representative 
substances for subgroup 4.4a (See Table 1). The Flavour Industry has informed that one of the 
representative substances, 5-methylfuran-3(2H)-one [FL-no: 13.157], is not in common use in the 
Flavour Industry and is no longer supported. As an alternative substance for testing within this 
subgroup, the Flavour Industry had proposed the structurally related substance of subgroup 4.4a, 2,5-
dimethylfuran-3(2H)-one [FL-no: 13.119]. Accordingly, additional genotoxicity data have been 
submitted on 2,5-dimethylfuran-3(2H)-one [FL-no: 13.119] and 4-acetyl-2,5-dimethylfuran-3(2H)-one 
[FL-no: 13.175] (Table 1).  
Table 1:  Representatives selected by EFSA for Subgroup 4.4 of FGE.220 
Representatives selected by EFSA for Subgroup 4.4 of FGE.220 (EFSA, 2008bc) 
Subgroup FL-no Register name for representatives Structural formula 
4.4a 13.157 5-Methylfuran-3(2H)-one 
Not supported any longer by EFFA and deleted from the Union List 
 
13.119 2,5-Dimethylfuran-3(2H)-one 
New representative substance suggested by EFFA 
 
13.175 4-Acetyl-2,5-dimethylfuran-3(2H)-one 
 
4.4b 13.010 4-hydroxy-2,5-dimethylfuran-3(2H)-one 
 
 
Sections 2-4 report the same information that was present in the earlier versions of FGE.220. 
Section 5 describes additional data submitted for subgroup 4.4b in FGE.220Rev1.  
Section 6 describes new information on representative substances of subgroup 4.4a.  
2. Presentation of the Substances in Flavouring Group Evaluation 220 
2.1. Description 
The present Flavouring Group Evaluation 220 (FGE.220) concerns 10 substances, which are presented 
in Table 2. The 10 substances correspond to subgroup 4.4 of FGE.19 (EFSA, 2008a). These 
substances are all α,β-unsaturated 3(2H)-furanones [FL-no: 13.010, 13.084, 13.085, 13.089, 13.099, 
13.117, 13.119, 13.157, 13.175 and 13.176]. Five of the 10 substances can only exist as ketones [FL-
no: 13.089, 13.117, 13.119, 13.157 and 13.175] (subgroup 4.4a). In the remaining five substances, the 
Flavouring Group Evaluation 220 Revision 2 
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α,β-double bond can be involved in keto-enol tautomerism as such [FL-no: 13.010, 13.084 and 
13.085] or after hydrolysis of the ester moiety [13.099 and 13.176] (subgroup 4.4b).  
A summary of their current evaluation status of both subgroups 4.4a and 4.4b by the JECFA is given 
in Table 3 (JECFA, 2006). 
The α,β-unsaturated aldehyde and ketone structures are considered by the Panel to be structural alerts 
for genotoxicity (EFSA, 2008a). Accordingly the available data on genotoxic or carcinogenic activity 
for the ten ketones in FGE.220 were considered in this FGE. 
The Panel has also taken into consideration the outcome of the predictions from five selected (Q)SAR 
models (Benigni & Netzeva, 2007a; Gry et al., 2007; Nikolov et al., 2007) on the ketones in the 
present FGE. The 10 alpha,beta-unsaturated ketones and their (Q)SAR predictions are described and 
summarised in Table 4. 
3. Toxicity 
3.1. (Q)SAR Predictions 
In Table 4 the outcomes of the (Q)SAR predictions for possible genotoxic activity in five in vitro 
(Q)SAR models (ISS Local Model-Ames test, DTU-NFI MultiCASE-Ames test, -Chromosomal 
aberration test in Chinese hamster ovary cells (CHO), -Chromosomal aberration test in Chinese 
hamster lung cells (CHL), and -Mouse lymphoma test) are presented. 
For none of the candidate substances in this FGE a prediction was obtained with the ISS Local Model 
for gene mutations in Salmonella TA100, as all substances were out of domain. The DTU-NFI 
MultiCase models for mutagenicity predicted negative (no genotoxic potential) in the Ames test for all 
10 substances, and also for three substances (all three in subgroup 4.4b) in the Mouse lymphoma 
assay. For one substance [FL-no: 13.157] from subgroup 4.4a, a positive response in the Mouse 
lymphoma assay was predicted. The other candidate substances were out of domain. All but four 
substances (from subgroup) were out of domain for both the Chromosomal aberration CHO and CHL 
models. The four substances from subgroup 4.4b were in the domain of the Chromosomal aberrations 
CHL model and for these four the application of the model resulted in a negative prediction. 
It is concluded that these models, except for the negative predictions for the substance in the DTU-NFI 
MultiCASE model for Ames test, do not seem to generate a reliable and reproducible pattern of 
predictions for this group. Negative predictions in mammalian cells were only available for four of the 
substances in subgroup 4.4b (Furan-3(2H)-ones in which the alpha,beta double bond can be involved 
in keto-enol tautomerism). One positive prediction was available for genotoxic activity in mammalian 
cells for a substance in subgroup 4.4a (Furan-3(2H)-ones). 
3.2. Carcinogenicity Studies 
A carcinogenicity study with chronic exposure is available for one substance in subgroup 4.4b 
In an OECD Guideline 451- and GLP-compliant study, groups of 60 male and 60 female Sprague-
Dawley rats were fed diets containing 0 (controls), 100, 200 or 400 mg 4-hydroxy-2,5-dimethylfuran-
3(2H)-one [FL-no: 13.010] per kg body weight (bw) per day for two years. Mean body weights and 
body weight gains of male and female rats exposed to 400 mg 4-hydroxy-2,5-dimethyl-3(2H)-
furanone/kg bw/day were decreased compared to those of the controls in the last part of the study. No 
neoplasms or non-neoplastic lesions were attributed to exposure to 4-hydroxy-5-dimethyl-3(2H)-
furanone. The NOAEL was 200 mg/kg bw/day (Kelly and Bolte, 2003). 
The Panel concluded that the study on 4-hydroxy-2,5-dimethylfuran-3(2H)-one [FL-no: 13.010] was 
valid and did not show a carcinogenic potential in rats. 
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Study validation and results are presented in Table 5. 
3.3. Genotoxicity Studies 
Genotoxicity studies are available for four of the candidate substances in FGE.220, as summarised in 
Tables 6 and 7. 
Subgroup 4.4a (Furan-3(2H)-ones) 
For one substance in subgroup 4.4a (2,5-dimethyl-3(2H)-furanone [FL-no: 13.119]), no mutagenic 
activity was observed in S. typhimurium in a valid assay. No experimental data were available for any 
of the other substances in this subgroup. 
Subgroup 4.4b (Furan-3(2H)-ones in which the alpha,beta double bond can be involved in keto-enol 
tautomerism). 
For three substances with available genotoxicity studies, which belong to subgroup 4.4b, the following 
results have been reported: 
4-Hydroxy-2,5-dimethylfuran-3(2H)-one [FL-no: 13.010] 
For 4-hydroxy-2,5-dimethylfuran-3(2H)-one [FL-no: 13.010] publications on in vitro and in vivo 
studies are available. In three studies the potential of the test substance to induce gene mutations in S. 
Typhimurium was studied. The substance was found positive in two valid studies and in one study 
with limited validity. The substance did not cause gene mutations in a valid study in Escherichia coli 
WP2 uvrA
-
. It was also observed that the substance caused DNA repair in a less relevant bacterial test 
and single strand breaks in purified DNA. 
All in vivo studies provided indications for a genotoxic potential. Two studies showing micronucleus 
formation in peripheral blood cells were considered valid (Hiramoto et al., 1996b; Hiramoto et al., 
1998); in a third study similar evidence but of limited validity was obtained (Xing et al., 1988). The 
latter authors also reported an increase in sister chromatid exchanges (SCE) in mouse bone marrow, 
but the validity of that observation could not be assessed. In addition, this endpoint is of questionable 
relevance for the assessment of genotoxicity. 
In addition to the genotoxicity observed in somatic cells, three studies provided evidence for 
genotoxicity in germ cells.  
The evidence of chromosome aberration induction in mouse germ cells provided in the study by Xing 
et al. (1988) is poor because it is essentially based on an increase of premature disjunction of sex 
chromosomes and autosomes at metaphase I. This effect could be considered at most an alert of 
possible subsequent missegregation events; even so, data have been published (Liang and Pacchierotti, 
1988) showing the lack of correlation between univalents at metaphase I and aneuploidy at metaphase 
II.  
Tian et al. (1992) reported an induction of SCE in spermatogonia. Incomplete information is given on 
the experimental protocol. There is a dose-dependent increase of SCE/cell, with each dose group 
significantly higher than the negative control. For these reasons, these data seem to be convincing 
although obtained on a small (3) number of animals/group. The relevance of SCE in spermatogonia as 
an indicator of heritable genetic damage is limited. 
In the same paper Tian et al. (Tian et al., 1992) reported the induction of micronuclei in early sperm 
cells. This test measures the induction of DNA lesions in preleptotene spermatocytes that can lead to 
breaks and fragments several days later, at the first or second meiotic division. The test has not been 
standardised and validated for routine regulatory application, but has been conducted by more than 
one laboratory in the world with consistent results. The study seems adequately performed. Staining 
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with Giemsa is not optimal and does not allow to distinguish among phases of spermatid 
differentiation as recommended by the guidelines (Russo, 2000). However, this drawback could hardly 
produce an overestimation of the effect, more likely, if any, an underestimation. 
4-Hydroxy-5-methylfuran-3(2H)-one [FL-no: 13.085] and 2-Ethyl-4-hydroxy-5-methyl-3(2H)-
furanone [FL-no: 13.084] 
Reverse mutations were also observed in S. typhimurium TA100, but not TA98 with 4-hydroxy-5-
methylfuran-3(2H)-one [FL-no: 13.085] and with 2-ethyl-4-hydroxy-5-methyl-3(2H)-furanone [FL-
no: 13.084]. The other strains were not tested. The same substances could induce single strand breaks 
in purified DNA. With 2-ethyl-4-hydroxy-5-methyl-3(2H)-furanone [FL-no: 13.084] also induction of 
micronuclei in peripheral erythrocytes was observed in two valid in vivo assays. 
Mechanistic data 
For the substances in subgroup 4.4b also mechanistic studies were carried out with [FL-no: 13.010, 
13.084 and 13.085], all of which were considered valid. These substances were identified as Maillard 
reaction products in soy sauce. When the substance [FL-no: 13.085] was incubated with supercoiled 
pBR 322 plasmid DNA, single strand breaks were observed at pH 4.4, but not at pH 7.4. When a spin 
trap was also present, formation of hydroxy radicals together with a carbon-centered radical could be 
demonstrated. Subsequent addition of superoxide dismutase and catalase inhibited the DNA breaking 
showing involvement of hydrogen peroxide. Potassium iodide, mannitol, sodium azide and ethanol 
were also inhibitory to the DNA breaking showing involvement of hydroxy radicals. Spin trapping 
agents and thiol compounds and metal chelators also effectively inhibited the breaking of DNA 
(Hiramoto et al., 1996a). Similar studies (Hiramoto et al., 1996b; Li et al., 1998) were carried out with 
[FL-no: 13.010 and 13.084] with the same results and it was also demonstrated that these substances 
are capable to reduce Fe
3+
 at neutral or alkaline pH (Li et al., 1998).  
Study results and comments on study validity are presented in Table 6 and 7. 
3.4. Conclusion on Genotoxicity and Carcinogenicity – Text taken from FGE.2207 (EFSA, 
2009) 
Apart from the negative predictions for the substances in the DTU-NFI MultiCASE model for the 
Ames test, the (Q)SAR models do not seem to generate a reliable and reproducible pattern of 
predictions on the genotoxicity for the substances in this FGE.  
For one substance in subgroup 4.4a (2,5-dimethyl-3(2H)-furanone [FL-no: 13.119]) no mutagenic 
activity was observed in S. typhimurium in a valid assay. This study result is insufficient to reach a 
conclusion as to the (absence) of genotoxicity for this subgroup. 
With several substances in subgroup 4.4b indications have been obtained in in vitro studies that the 
genetic damage they cause is related to the generation of reactive oxygen species as a result of redox 
cycling in combination with metal ions present in the media. The valid positive in vivo data were 
obtained with high dose levels that may be anticipated to have exhausted the anti-oxidant capacity of 
the target cells. This, in combination with the absence of carcinogenicity observed in a valid 
carcinogenicity study in rats with one of the substances [FL-no: 13.010], which was tested positive in 
the genotoxicity assays, takes away a concern for genotoxic events resulting in carcinogenicity in 
somatic cells. 
For two of the studies in which genotoxic effects were observed in germ cells in vivo the studies had 
limited validity and/or address endpoints that may have limited relevance for the assessment of 
genotoxic potential. The Panel noted that a positive result was obtained in a micronucleus study in 
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early sperm cells. However, a micronucleus test does not discriminate between aneuploidy and 
chromosomal breakage. The observed effects in the germ cells could be the result of the 
malsegregation of chromosomes which is generally considered a thresholded event. They may 
alternatively be the result of the (thresholded) generation of reactive oxygen species. 
4. Conclusions – Text taken from FGE.2208 (EFSA, 2009) 
For the substances in subgroup 4.4a [FL-no: 13.089, 13.117, 13.119, 13.157 and 13.175], the Panel 
considered that presently the available data on genotoxicity are too limited to evaluate these 
substances through the Procedure. Additional studies are needed as outlined in the Genotoxicity Test 
Strategy for Substances belonging to Subgroups of FGE.19 (EFSA, 2008b). 
For the substances in subgroup 4.4b [FL-no: 13.010, 13.084, 13.085, 13.099 and 13.176], evidence for 
genotoxicity was obtained in vitro and in vivo. Evidence is available from in vitro studies that the 
genotoxicity of the candidate substances in this subgroup may be caused by indirect (thresholded) 
mechanisms of action (in particular generation of reactive oxygen species). The concern for 
carcinogenicity is alleviated, since one of the substances, for which positive genotoxicity data in mice 
were obtained, was not carcinogenic in a valid chronic assay in rats. Therefore, no further genotoxicity 
tests in somatic cells are required. However, some evidence was also available that this substance 
might elicit genotoxic effects in germ cells, which theoretically may result in reduced reproductive 
capacity or in inheritable genetic damage. Reduced reproductive capacity and inheritable genetic 
damage are toxicological endpoints which differ from carcinogenicity and therefore, the negative 
results for the carcinogenicity study cannot be used to overrule this concern. Also it is not clear if (and 
if so to what extent) the thresholded mechanism mentioned above would be relevant for genotoxic 
effects in the germ cells. Therefore, the Panel concluded that presently these five substances cannot be 
evaluated through the Procedure. 
The Panel recognised that the studies which provided indications for germ cell genotoxicity are of 
limited validity. For that reason a robust GLP-controlled cytogenetic investigation in mouse 
spermatocytes according to the OECD Guideline 483 is requested. 
5. Additional data submitted by Industry for Subgroup 4.4b (FGE.220Rev1) 
In response to the EFSA request in FGE.220, of a cytogenetic study in mouse spermatocytes (OECD 
TG 483), Industry has submitted the following data: 
 Two-year carcinogenicity bioassay in rats with a substance coded  ST 07 C99 (this is the study on 
[FL-no: 13.010] by Kelly & Bolte, 2003); 
 Oral male fertility study of FURANEOL =  4-Hydroxy-2,5-dimethylfuran-3(2H)-one [FL-no: 
13.010] (test article code ST17C07) in rats (Sloter, 2008); 
 Oral micronucleus assay in bone marrow cells of the mouse with NEOFURANEOL (no 
identification of this substance is available) (Honarvar, 2008b); 
 Mouse lymphoma (TK) specific locus mutation assay with compound 0478/1 (Ross & Harris, 
1979a). 
5.1. Evaluation of Additional Data for Subgroup 4.4b (FGE.220Rev1) 
The Panel noted that among the studies submitted by Industry only the rat fertility study, which 
includes also the analysis of dominant lethals, is considered relevant for the specific EFSA request. 
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The 2-year carcinogenicity bioassay in rats by Kelly and Bolte (Kelly and Bolte, 2003) was already 
evaluated by the Panel in the previous version of this FGE (Section 3.2 (Table 5)). It was considered 
as a valid, negative study, however not relevant for the evaluation of possibly inheritable damage. 
Also the mouse bone marrow micronucleus assay with neofuraneol (Honarvar, 2008b) and the in vitro 
mouse lymphoma TK assay (Ross and Harris, 1979a) are considered not relevant to clear the concern 
for possible inheritable damage. Furthermore, an adequate identification of the test substance 
Neofuraneol was not possible, due to incomplete reporting. For these reasons these three studies will 
not be further considered in this section. 
Oral Male Fertility Study of 4-Hydroxy-2,5-dimethylfuran-3(2H)-one [FL-no: 13.010] in Rats (Sloter, 
2008) 
The objective of this study, performed according to ICH Guideline 4.1.1 (ICH, 1996) under GLP, was 
to determine the potential effects of 4-hydroxy-2,5-dimethylfuran-3(2H)-one [FL-no: 13.010] on 
mating, fertility and gonadal function in male rats with two separate mating trials. 4-Hydroxy-2,5-
dimethylfuran-3(2H)-one was administered by gavage once daily to three groups of 25 male 
Crl:CD(SD) rats. Dosage levels were 100, 500 and 1000 mg/kg bw/day. A concurrent control group of 
25 males received the vehicle (propylene glycol) on a comparable regimen. The first mating (Phase I), 
following 2 weeks of male administration, using untreated females, was conducted to detect potential 
elicitation of early genotoxic effects on the embryo with reduced risk of test-article related deficiencies 
in mating or fertility. The second mating (Phase II), following 9 weeks of male dose administration, 
was conducted following male exposure throughout a complete spermatogenic cycle using a second 
set of untreated females.   
There was no test-article related mortality noted in this study. A slightly lower mean body-weight gain 
was noted in the 1000 mg/kg/day group when evaluated for the overall treatment period. No test-
article related effects on male reproductive performance were observed at 100, 500 and 1000 
mg/kg/day when males were mated with Phase I or Phase II females. In particular, there were no 
effects on spermatogenic endpoints (mean testicular and epididymal sperm numbers, sperm production 
rate, motility and morphology, reproductive organs or macroscopic findings) at any of the doses 
tested. The mean percentage of sperm with abnormal morphology (separated head and flagellum) was 
slightly higher in the 500 and 1000 mg/kg/day groups; however, this was primarily attributed to a 
single male in the respective groups  and therefore not considered test-article related. The number of 
females mated and the number of pregnant females was comparable to controls. Uterine examination 
was performed for both Phase I and Phase II females. The analysis of embryonic data (corpora lutea, 
implantation sites, viable embryos, dead embryos, early resorptions, late resorptions, total resorptions, 
post- and pre-implantation losses) did not reveal dominant lethal effects. The study does not indicate a 
potential of 4-hydroxy-2,5-dimethylfuran-3(2H)-one [FL-no: 13.010] to affect male fertility. This 
study can be considered to be equivalent to an OECD 478 Dominant Lethal assay. The Dominant 
Lethal assay has been recommended as follow-up study in case of positive results in the OECD TG 
483 (Eastmond et al., 2009). On this basis the Panel considers it acceptable to substitute the requested 
study according to OECD Guideline 483 with the Dominant Lethal test. 
Study results and comments on study validity are presented in Table 8. 
5.2. Conclusion on Additional Data for Subgroup 4.4b (EFSA, FGE.220Rev1) 
The results of a valid rat fertility and dominant lethal study have shown that 4-hydroxy-2,5-
dimethylfuran-3(2H)-one is unable to induce both adverse effects on male rat reproductive capacity 
and dominant lethality. On this basis the Panel concludes that for this substance there is no concern for 
its potential to induce heritable genetic damage or adverse effects on male reproductive capacity. 
Accordingly, the substances in subgroup 4.4b of FGE.19 [FL-no: 13.010, 13.084, 13.085, 13.099 and 
13.176] can be evaluated using the Procedure.  
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Since no data were submitted to further evaluate the genotoxic potential of the substances in subgroup 
4.4a, the Panel in FGE.220Rev1 maintained its position that for this subgroup additional data on 
genotoxicity are needed. 
6. Additional data submitted by Industry for Subgroup 4.4a 
In response to the EFSA request in FGE.220 for additional genotoxicity data for subgroup 4.4a the 
Flavour Industry (IOFI, 2012) has submitted in vitro genotoxicity data on: 
 2,5-Dimethylfuran-3(2H)-one [FL-no: 13.119] (Ames test and in vitro micronucleus assay) 
 4-Acetyl-2,5-dimethylfuran-3(2H)-one [FL-no: 13.175] (Ames test and in vitro micronucleus 
assay) 
6.1. In vitro Genotoxicity Studies for Subgroup 4.4a 
Bacterial mutation assays 
2,5-Dimethylfuran-3(2H)-one [FL-no: 13.119] 
2,5-Dimethylfuran-3(2H)-one [FL-no: 13.119] was tested in Salmonella typhimurium strains TA98, 
TA100, TA1535, TA1537 and TA102 in the absence or presence of S9-mix (Sokolowski, 2007) in a 
GLP study and according to OECD Test Guideline 471. In the first experiment the concentrations 
tested were 3, 10, 33, 100, 333, 1000, 2500 and 5000 μg/plate, and plate incorporation methodology 
was used. In the second experiment the concentrations were 33, 100, 333, 1000, 2500 and 5000 
μg/plate of 2,5-dimethylfuran-3(2H)-one [FL-no: 13.119], and treatments in the absence and in the 
presence of S9-mix used the pre-incubation method. No toxic effects, evident as a reduction in the 
number of revertants, occurred in the test groups with and without metabolic activation. The solvent 
control data reported for strain TA102 in the absence of S9-mix, indicated slightly increased numbers 
of revertant colony numbers (538 ± 28) compared to historical controls (407.1 ± 78.3). Since the effect 
is small in the control, the effect is considered by the study director to be based upon biologically 
irrelevant fluctuations in the number of colonies. Thus, the study design complied with current 
recommendations and an acceptable top concentration was achieved. There was no evidence of any 
mutagenic effect induced by 2,5-dimethylfuran-3(2H)-one [FL-no: 13.119] in any of the strains, either 
in the absence or presence of S9-mix. 
4-Acetyl-2,5-dimethylfuran-3(2H)-one [FL-no: 13.175] 
4-Acetyl-2,5-dimethylfuran-3(2H)-one [FL-no: 13.175] was tested in S. typhimurium strains TA98, 
TA100, TA1535, TA1537 and TA102 in the absence and presence of S9-mix (Bowen, 2011) in a GLP 
study and according to OECD Test Guideline 471. In the first experiment the concentrations were 
0.32, 1.6, 8, 40, 200, 1000 and 5000 μg/plate of 4-acetyl-2,5-dimethylfuran-3-(2H)-one [FL-no: 
13.175] and the plate incorporation methodology was used. Slight thinning of the background lawn 
was observed at 5000 μg/plate for all test strains in the absence and presence of S9-mix. In the second 
experiment the concentrations were 78.13, 156.3, 312.5, 625, 1250, 2500 and 5000 μg/plate and the 
treatments in the presence of S9-mix used the pre-incubation method. No clear evidence of toxicity 
was observed. Thus, the study design complied with current recommendations and an acceptable top 
concentration was achieved. There was no evidence of any mutagenic effect induced by 4-acetyl-2,5-
dimethylfuran-3(2H)-one [FL-no: 13.175] in any of the strains, either in the absence or presence of 
S9-mix. 
 
Micronucleus Assays 
2,5-Dimethylfuran-3(2H)-one [FL-no: 13.119] 
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2,5-Dimethylfuran-3(2H)-one [FL-no: 13.119] was evaluated in an GLP in vitro micronucleus assay in 
human peripheral blood lymphocytes for its ability to induce chromosomal damage or aneuploidy in 
the presence and absence of rat S9-mix fraction as an in vitro metabolising system. Cells were 
stimulated for 48 hours with phytohaemagglutinin to produce exponentially growing cells, and then 
treated for 3 hours (followed by 21 hours recovery) with 0, 900, 1000 or 1120 μg/ml of 2,5-
dimethylfuran-3(2H)-one [FL-no: 13.119] in the absence and in the presence of S9-mix. The levels of 
cytotoxicity (reduction in replication index) at the top concentrations were 12 % and 2 % respectively. 
In a parallel assay, cells were treated for 24 hours with 0, 900, 1000 and 1120 μg/ml of 2,5-
dimethylfuran-3(2H)-one [FL-no: 13.119] in the absence of S9-mix with no recovery period. The top 
concentration induced 22 % cytotoxicity. There were 2 replicate cultures per treatment, and 1000 
binucleate cells per replicate (i.e. 2000 cells per concentration) were scored for micronuclei. Thus the 
study design complies with current recommendations (OECD Test Guideline 487), and acceptable 
levels of cytotoxicity were achieved at the top concentrations used in all parts of the study. No 
evidence of chromosomal damage or aneuploidy was observed by increased levels of micronucleated 
binucleate cells (MNBN) in the presence or absence of S9-mix metabolic activation (Lloyd, 2011). 
4-Acetyl-2,5-dimethylfuran-3(2H)-one [FL-no 13.175] 
In a similar GLP experiment, human peripheral lymphocytes were stimulated for 48 hours with 
phytohaemagglutinin to produce exponentially growing cells, and then treated for 3 hours (followed 
by 21 hours recovery) with 0, 1000, 1250 or 1542 μg/ml of 4-acetyl-2,5-dimethylfuran-3(2H)-one 
[FL-no: 13.175] in the absence and in the presence of S9-mix. The levels of cytotoxicity (reduction in 
replication index) at the top concentrations were 20 % and 7 % respectively. In a parallel assay, cells 
were treated for 24 hours with 0, 400, 600, 900 and 950 μg/ml of 4-acetyl-2,5-dimethylfuran-3(2H)-
one [FL-no: 13.175] in the absence of S-9 with no recovery period. The top concentration induced 
54% cytotoxicity. There were two replicate cultures per treatment, and 1000 binucleate cells per 
replicate were scored for micronuclei. Thus the study design complies with current recommendations 
(OECD Test Guideline 487), and acceptable levels of cytotoxicity were achieved at the top 
concentrations used in all parts of the study. Initially (following the scoring of 1000 binucleate 
cells/culture), treatment of cells for 3 hours with a 21 hour recovery period in the presence of S9-mix 
resulted in mean frequencies of MNBN cells (0.55 %, 0.85 % and 1.25 %, at 1000, 1250 and 1542 
μg/ml, respectively) that were significantly higher (p ≤ 0.01) compared with those observed in 
concurrent controls (0.20%) at all three concentrations analysed, giving 3 %, 0 % and 7 % reductions 
in Replication Index, respectively (Annex I, Table 10, Lloyd, 2012). The MNBN cell frequencies 
exceeded the normal range (0.1% to 1.1 %) only in single cultures at 1250 and 1542 μg/ml (1.2 % and 
1.6 %, respectively). It was noted that one of the solvent control replicates fell to 0 %, which is outside 
of historical control levels and would have impacted the statistical significance. To confirm this result 
additional 1000 binucleate cells were scored for the vehicle controls “C” and “D” replicate cultures 
derived from new human blood cultures and an additional 1000 binucleate cells were scored from each 
of the three test article concentrations analysed, derived from the same human blood culture used in 
the first experiment. Following the additional scoring, the mean frequencies of MNBN cells were 
significantly higher but at lower statistical level (p ≤ 0.05), compared to those observed in the 
concurrent vehicle controls at the two highest concentrations analysed (1250 and 1542 μg/ml) (Annex 
I, Table 10, Lloyd, 2012). It was noted that only one culture at 1542 μg/ml (1.25 %) exceeded the 
normal range. The Panel noted that the additional scoring was conducted with an unjustified and non-
homogeneous approach: for the solvent controls the additional 1000 cells were derived from new 
blood lymphocytes cultures, whereas for the additional scoring of the treated samples, cells were 
derived from the same blood cultures used in the first experiment. Overall, differently from the 
authors, the Panel concluded that the results of the in vitro micronucleus assay in the presence of S9-
mix have to be considered as equivocal instead of negative and therefore the test should be repeated 
(Lloyd, 2012). 
Study results and comments on study validity are presented in Table 9. 
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6.2. Conclusions on Additional Data Submitted for Subgroup 4.4a  
2,5-Dimethylfuran-3(2H)-one [FL-no: 13.119] did not induce mutations in the Ames test and did not 
induce increased levels of micronuclei in an in vitro micronucleus assay with and without metabolic 
activation. The Panel therefore concluded that [FL-no: 13.119] does not give rise to concern with 
respect to genotoxicity and accordingly can be evaluated using the Procedure.  
4-Acetyl-2,5-dimethylfuran-3(2H)-one [FL 13.175] did not induce mutations in the Ames test with 
and without metabolic activation and did not induce increased levels of micronuclei in an in vitro 
micronucleus assay in the absence of S9-mix. However, the results of the micronucleus assay in the 
presence of S9-mix were considered by the Panel to be equivocal. Therefore, the results of the in vitro 
micronucleus assay should be clarified, e.g. by repetition of the study in the presence of S9-mix 
applying the same conditions and possibly in addition modified conditions, or by a combined in vivo 
micronucleus and comet assay, including analysis of liver. This is also applicable to 2,5-Dimethyl-4-
methoxyfuran-3(2H)-one [FL-no:13.089] and 2,5-Dimethyl-4-ethoxyfuran-3(2H)-one [FL-no:13.117] 
which are covered by the representative substance 4-Acetyl-2,5-dimethylfuran-3(2H)-one [FL-
no:13.175]. 
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Table 2:  Specification Summary of the Substances in the Flavouring Group Evaluation 220 (JECFA, 2006) 
Specification Summary of the Substances in the Flavouring Group Evaluation 220 (JECFA, 2006) 
FL-no 
JECFA-no 
EU Register name Structural formula FEMA no 
CoE no 
CAS no 
Phys.form 
Mol.formula 
Mol.weight 
Solubility 1) 
Solubility in ethanol 
2) 
Boiling point, °C 
3) 
Melting point, °C 
ID test 
Assay minimum 
Refrac. Index 4) 
Spec.gravity 5) 
Substances in subgroup 4.4a (Furan-3(2H)-ones) 
13.089 
1451 
2,5-Dimethyl-4-methoxyfuran-3(2H)-one 
 
3664 
 
4077-47-8 
Liquid 
C7H10O3 
142.15 
Insoluble 
Soluble 
61-63 (0.4 hPa) 
 
NMR 
97 % 
1.475-1.481 
1.091-1.097 
13.117 
 
2,5-Dimethyl-4-ethoxyfuran-3(2H)-one 
 
 
 
65330-49-6 
Solid 
C8H12O3 
156.18 
 
1 ml in 1 ml 
251 
60 
 
95 % 
n.a. 
n.a. 
13.119 
 
2,5-Dimethylfuran-3(2H)-one 
 
 
11066 
14400-67-0 
Liquid 
C6H8O2 
112.13 
 
1 ml in 1 ml 
68 (16 hPa) 
 
 
95 % 
1.473-1.479 
1.050-1.060 
13.157 5-Methylfuran-3(2H)-one 
 
 
 
3511-32-8 
Liquid 
C5H6O2 
98.10 
 
1 ml in 1 ml 
59 (13 hPa) 
 
 
95 % 
1.492-1.498 
13.175 
 
4-Acetyl-2,5-dimethylfuran-3(2H)-one 
 
 
 
 
Solid 
C8H10O3 
154.17 
 
1 ml in 1 ml 
283 
34 
 
95 % 
n.a. 
n.a. 
Substances in subgroup 4.4b (Furan-3(2H)-ones in which the alpha,beta-unsaturated double bond can be involved in keto-enol tautomerism) 
13.010 
1446 
4-Hydroxy-2,5-dimethylfuran-3(2H)-one 
 
3174 
536 
3658-77-3 
Solid 
C6H8O3 
128.13 
Insoluble 
Soluble 
n.a. 
78-80 
IR 
98 % 
n.a. 
n.a. 
13.084 
1449 
2-Ethyl-4-hydroxy-5-methyl-3(2H)-furanone 
 
3623 
 
27538-09-6 
Liquid 
C7H10O3 
142.15 
Soluble 
Soluble 
103 (20 hPa) 
 
NMR 
96 % 
1.509-1.514 
1.133-1.143 
13.085 
1450 
4-Hydroxy-5-methylfuran-3(2H)-one 
 
3635 
11785 
19322-27-1 
Solid 
C5H6O3 
114.10 
Soluble 
Soluble 
n.a. 
126-133 
NMR 
97 % 
n.a. 
n.a. 
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Specification Summary of the Substances in the Flavouring Group Evaluation 220 (JECFA, 2006) 
FL-no 
JECFA-no 
EU Register name Structural formula FEMA no 
CoE no 
CAS no 
Phys.form 
Mol.formula 
Mol.weight 
Solubility 1) 
Solubility in ethanol 
2) 
Boiling point, °C 
3) 
Melting point, °C 
ID test 
Assay minimum 
Refrac. Index 4) 
Spec.gravity 5) 
13.099 
1456 
4-Acetoxy-2,5-dimethylfuran-3(2H)-one 
 
3797 
 
4166-20-5 
Liquid 
C8H10O4 
170.17 
Slightly soluble 
Soluble 
243 
 
NMR 
85 % 
1.476-1.480 
1.159-1.167 
13.176 
1519 
Furaneyl butyrate 
 
3970 
 
 
Liquid 
C10H14O4 
198.22 
Insoluble 
Soluble 
287 
 
NMR 
93 % 
1.467-1.473 
1.095-1.103 
1) Solubility in water, if not otherwise stated. 
2) Solubility in 95%  ethanol, if not otherwise stated. 
3) At 1013.25 hPa, if not otherwise stated. 
4) At 20°C, if not otherwise stated. 
5) At 25°C, if not otherwise stated. 
n.a.: not applicable. 
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Table 3:  Summary of Safety Evaluation Applying the Procedure (Based on Intakes Calculated by the MSDI Approach) 
Summary of Safety Evaluation Applying the Procedure (based on intakes calculated by the MSDI approach) (JECFA, 2006) 
FL-no 
JECFA-no 
EU Register name Structural formula MSDI 1) 
( g/capita/day) 
Class 2) 
Evaluation procedure path 3) 
Outcome on the 
named compound 
[ 4) or 5] 
Outcome on the material of commerce 
[6), 7), or 8)] 
Evaluation remarks 
Substances in subgroup 4.4a (Furan-3(2H)-ones) 
13.089 
1451 
2,5-Dimethyl-4-
methoxyfuran-3(2H)-one 
 
12 
0.7 
Class II 
A3: Intake below threshold 
4) Evaluted in FGE.220 and FGE.220Rev2, 
additional data required. 
 
13.117 
 
2,5-Dimethyl-4-
ethoxyfuran-3(2H)-one 
 
0.018 
 
 
No evaluation 
Not evaluated by 
JECFA 
Evaluted in FGE.220, additional data 
required and FGE.220Rev2, 
 
13.119 
 
2,5-Dimethylfuran-3(2H)-
one 
 
1.9 
 
 
No evaluation 
Not evaluated by 
JECFA 
Evaluted in FGE.220, additional data 
required. 
Based on new data, evaluted in 
FGE.220Rev2, genotoxicity concern could 
be ruled out. 
 
13.157 5-Methylfuran-3(2H)-
one 
 
0.0061  
No evaluation 
Not evaluated by 
JECFA 
Evaluted in FGE.220, additional data 
required.. 
No longer supported by 
Industry. 
13.175 
 
4-Acetyl-2,5-dimethylfuran-
3(2H)-one 
 
1.3 
 
 
No evaluation 
Not evaluated by 
JECFA 
Evaluted in FGE.220, additional data 
required and FGE.220Rev2, 
 
 
Substances in subgroup 4.4b (Furan-3(2H)-ones in which the alpha,beta-unsaturated double bond can be involved in keto-enol tautomerism) 
13.084 
1449 
2-Ethyl-4-hydroxy-5-
methyl-3(2H)-furanone 
 
203 
13 
Class II 
A3: Intake below threshold 
4) Evaluted in FGE.220Rev1, genotoxicity 
concern could be ruled out. 
EFSA allocated the substance to Class III. 
No safety concern at the estimated level of 
intake based on the MSDI approach. 
 
No safety concern at the estimated 
level of intake based on the MSDI 
approach. 
 
13.085 
1450 
4-Hydroxy-5-methylfuran-
3(2H)-one 
 
47.8 
0.07 
Class II 
A3: Intake below threshold 
4) Evaluted in FGE.220Rev1, genotoxicity 
concern could be ruled out. 
EFSA allocated the substance to Class III. 
No safety concern at the estimated level of 
intake based on the MSDI approach. 
 
No safety concern at the estimated 
level of intake based on the MSDI 
approach. 
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Summary of Safety Evaluation Applying the Procedure (based on intakes calculated by the MSDI approach) (JECFA, 2006) 
FL-no 
JECFA-no 
EU Register name Structural formula MSDI 1) 
( g/capita/day) 
Class 2) 
Evaluation procedure path 3) 
Outcome on the 
named compound 
[ 4) or 5] 
Outcome on the material of commerce 
[6), 7), or 8)] 
Evaluation remarks 
13.099 
1456 
4-Acetoxy-2,5-
dimethylfuran-3(2H)-one 
 
400 
8 
Class II 
A3: Intake below threshold 
4) Evaluted in FGE.220Rev1, genotoxicity 
concern could be ruled out. 
EFSA allocated the substance to Class III. 
No safety concern at the estimated level of 
intake based on the MSDI approach. 
 
No safety concern at the estimated 
level of intake based on the MSDI 
approach. 
 
13.010 
1446 
4-Hydroxy-2,5-
dimethylfuran-3(2H)-one 
 
4483 
5203 
Class II 
A3: Intake above threshold,  
A4: Not endogenous,  
A5: Adequate NOAEL exists 
4) Evaluted in FGE.220Rev1, genotoxicity 
concern could be ruled out. 
No safety concern at the estimated level of 
intake based on the MSDI approach. 
No safety concern at the estimated 
level of intake based on the MSDI 
approach. 
13.176 
1519 
Furaneyl butyrate 
 
4.2 
4 
Class III 
No evaluation 
 Evaluted in FGE.220Rev1, genotoxicity 
concern could be ruled out. 
No safety concern at the estimated level of 
intake based on the MSDI approach. 
No safety concern at the estimated 
level of intake based on the MSDI 
approach. 
Register name to be changed to 4-
Butyroxy-2,5-dimethyl-3(2H)-
furanone (EFFA, 2012). 
1) EU MSDI: Amount added to food as flavour in (kg / year) x 10E9 / (0.1 x population in Europe (= 375 x 10E6) x 0.6 x 365)  =  µg/capita/day. 
2) Thresholds of concern: Class I = 1800 µg/person/day, Class II = 540 µg/person/day, Class III = 90 µg/person/day. 
3) Procedure path A substances can be predicted to be metabolised to innocuous products.  Procedure path B substances cannot. 
4) No safety concern based on intake calculated by the MSDI approach of the named compound. 
5) Data must be available on the substance or closely related substances to perform a safety evaluation. 
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Table 4:  QSAR Predictions on Mutagenicity in Five Models for 10 Ketones from Subgroup 4.4 
FL-no 
JECFA-no 
Sub- 
group 
EU Register name Structural formula FEMA no 
CoE no 
CAS no 
ISS Local 
Model 
Ames Test 
TA100 
MultiCASE  
Ames test 
  
MultiCASE 
Mouse 
lymphoma test 
MultiCASE 
Chromosomal 
aberration test in 
CHO 
MultiCASE 
Chromosomal 
aberration 
test in CHL 
Substances in subgroup 4.4a (Furan-3(2H)-ones) 
13.089 
1451 
4.4 2,5-Dimethyl-4-methoxyfuran-3(2H)-
one 
 
3664 
- 
4077-47-8 
OD* NEG OD* OD* OD* 
13.117 
 
4.4 2,5-Dimethyl-4-ethoxyfuran-3(2H)-one 
 
- 
- 
65330-49-6 
OD* NEG OD* OD* OD* 
13.119 
 
4.4 2,5-Dimethylfuran-3(2H)-one 
 
- 
11066 
14400-67-0 
OD* NEG OD* OD* OD* 
13.157 
 
4.4 5-Methylfuran-3(2H)-one 
 
- 
- 
3511-32-8 
OD* NEG POS OD* OD* 
13.175 
 
4.4 4-Acetyl-2,5-dimethylfuran-3(2H)-one 
 
- 
- 
- 
OD* NEG OD* OD* OD* 
Substances in subgroup 4.4b (Furan-3(2H)-ones in which the alpha,beta-unsaturated double bond can be involved in keto-enol tautomerism) 
13.010 
1446 
4.4 4-Hydroxy-2,5-dimethylfuran-3(2H)-
one 
 
3174 
536 
3658-77-3 
OD* NEG NEG OD* NEG 
13.084 
1449 
4.4 2-Ethyl-4-hydroxy-5-methyl-3(2H)-
furanone 
 
3623 
- 
27538-09-6 
OD* NEG NEG OD* NEG 
13.085 
1450 
4.4 4-Hydroxy-5-methylfuran-3(2H)-one 
 
3635 
11785 
19322-27-1 
OD* NEG NEG OD* NEG 
13.099 
1456 
4.4 4-Acetoxy-2,5-dimethylfuran-3(2H)-one 
 
3797 
- 
4166-20-5 
OD* NEG OD* OD* OD* 
13.176 4.4 Furaneyl butyrate 
 
3970 
- 
- 
OD* NEG OD* OD* NEG 
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Column 2: Structure group 4.4: , -unsaturated ketones.  
Column 6: Local model on aldehydes and ketones, Ames TA100. (NEG: Negative; POS: Positive; OD*: out of domain). 
Column 7: MultiCase Ames test (OD*: Out of domain; POS: Positive; NEG: Negative; EQU: Equivocal). 
Column 8: MultiCase Mouse Lymphona test (OD*: Out of domain; POS: Positive; NEG: Negative; EQU: Equivocal). 
Column 9: MultiCase Chromosomal aberration in CHO (OD*: Out of domain; POS: Positive; NEG: Negative; EQU: Equivocal). 
Column 10: MultiCase Chromosomal aberration in CHL (OD*: Out of domain; POS: Positive; NEG: Negative; EQU: Equivocal). 
* OD, out of applicability domain: not matching the range of conditions where a reliable prediction can be obtained in this model. These conditions may be physicochemical, structural, biological, etc. 
 
 
Table 5:  Carcinogenicity Studies 
Carcinogenicity Studies 
Chemical Name [FL-no]  Species; Sex 
No./Group 
Route  Dose levels Duration Results Reference Comments 
4-hydroxy-2,5-dimethylfuran-3(2H)-
one [13.010] 
Rats; Male, Female 
60/sex/group 
Diet 0, 100, 200, or 400 
mg/kg bw/day 
2 years Males: No increase in tumour incidences 
Females: No increases in tumour incidences 
(Kelly and Bolte, 2003) 
 
Valid (GLP/OECD compliant). 
The NOAEL was 200  mg/kg 
bw/day based on  reduced mean 
body weight at the highest dose. 
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Table 6:  Genotoxicity (in vitro) 
Genotoxicity (in vitro) 
Chemical Name [FL-no]  Test System Test Object  Concentration Reported 
Result  
Reference  Comments e 
4-hydroxy-2,5-dimethylfuran-
3(2H)-one [13.010] 
Reversed mutation S. typhimurium TA1535, 
TA1537, TA1538,TA100 
and TA98 
10.0, 33.3, 100.0, 333.3, 1000, 
2000, 3300, 4000, 6000, 8000 
µg/plate 
Positivea, b (Gilroy et al., 1978) 
 
Valid. Unpublished non-GLP study. The report 
contains sufficient details. Result is considered 
valid. 
Reversed mutation S. typhimurium TA100 and 
TA98 
0 - 10000 µg/plate Positivea, b (Hiramoto et al., 1996b) 
 
Valid. Positive in TA100 (+/– S9); negative in 
TA 98 (+/- S9). 
Reversed mutation S. typhimurium TA100, 
TA102, TA98 and TA97 
500 - 4000 µg/plate Positivea, c (Xing et al., 1988) 
 
Limited validity. No methodological details, 
but stated to be performed according to (Maron 
and Ames, 1983). Some  errors reduce the 
trustworthiness of the paper. 
Reversed mutation E. coli WP2 uvrA- 10.0, 33.3, 100.0, 333.3, 1000, 
3300 µg/plate 
Negative (Gilroy et al., 1978) 
 
Valid. Unpublished non-GLP study. The report 
contains sufficient details. Result is considered 
valid. 
DNA damage  B. subtilis H17 (Rec+) and 
M45 (Rec-) 
20, 40, 60, 80, 120 µg/disc Positive (Xing et al., 1988) 
 
Validity cannot be evaluated (Test system with 
low predictive value for genotoxicity).  No 
methodological details, but stated to be 
performed according to (Kada et al., 1972). 
DNA strand breaks  pBR322 DNA 2.6 - 780 µmol/l 
(0.3 - 100 mg/l) 
Positive (Hiramoto et al., 1996b) 
 
Valid. Single strand breaks caused by redox 
cycling of the substance in combination with 
metal ions, generating reactive oxygen species. 
4-Hydroxy-5-methylfuran-
3(2H)-one [13.085] 
 
Reversed mutation S. typhimurium TA100 and 
TA98 
0 - 5000 µg/plate Positivea, b (Hiramoto et al., 1996a) 
 
Limited validity. Limited due to uncertainty of 
test substance. Positive in TA100 (+/– S9); 
negative in TA 98 (+/- S9). 
DNA strand breaks  pBR322 DNA 0 - 900 µmol/l 
(0 - 103mg/l) 
Positivea, d (Hiramoto et al., 1996a) 
 
Valid. Single strand breaks caused by redox 
cycling of the substance in combination with 
metal ions, generating reactive oxygen species. 
2,5-Dimethyl-3(2H)-Furanone 
[13.119] 
Reverse mutation S. typhimurium TA1535, 
TA1537, TA98,TA100 and 
TA102,  
0 - 5000 µg/plate Negative (RCC - CCR, 2007) 
 
Valid. According to current guidelines. 
2-ethyl-4-hydroxy-5-methyl-
3(2H)-furanone [13.084] 
Reversed mutation S. typhimurium TA100 and 
TA98 
0 - 10000 µg/plate Positivea, b (Li et al., 1998) 
 
 Valid. Positive with and without S9 in TA 
100; negative in TA98 (+/- S9). 
DNA strand breaks pBR322 DNA 0 - 2000 M Positive
d (Li et al., 1998) 
 
Valid. Single strand breaks caused by redox 
cycling of the substance in combination with 
metal ions, generating reactive oxygen species. 
a: With and without metabolic activation provided by S9 (9000 x g supernatant from rodent liver). 
b: Positive results only observed in TA100. 
c: Positive results in all strains at the highest dose tested. 
d: Only positive without inhibitors of redox cycling and ROS scavengers. 
e: Validity of genotoxicity studies: 
 Valid. 
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 Limited validity (e.g. if certain aspects are not in accordance with OECD guidelines or current standards and / or limited documentation). 
 Insufficient validity (e.g. if main aspects are not in accordance with any recognised guidelines (e.g. OECD) or current standards and/or inappropriate  test system). 
 Validity cannot be evaluated (e.g. insufficient documentation, short abstract only, too little experimental details provided). 
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Table 7:  Genotoxicity (in vivo) 
Genotoxicity (in vivo) 
Chemical Name [FL-no]  Test System Test Object  Route Dose Reported Result  Reference  Comments a 
4-hydroxy-2,5-dimethylfuran-
3(2H)-one [13.010] 
Micronucleus 
formation 
Mouse, bone marrow Not stated 0, 186, 232 or 309 
mg/kg bw 
Positive (Xing et al., 1988) 
 
Limited validity. Important data not 
given; Reference to methodological 
description could not be traced. 
Chromosomal 
aberration 
Mouse spermatocytes Not stated 0, 232, 464 or 928 
mg/kg bw 
Positive (Xing et al., 1988) Limited validity. Important data not 
given. Reference to methodological 
description could not be traced. 
Predominant aberration: malsegregation 
of chromosomes. 
Sister chromatid 
exchange 
Mouse, bone marrow Intra-
abdominal 
injection 
0, 185, 232, 303 
mg/kg 
Positive (Xing et al., 1988) Validity cannot be assessed. Dose-related 
increase; statistically significant at all 
dose levels, but max increase < 2-fold. 
Effect not adequately specified; very 
intense exposure to BrdU.  Non-validated 
protocol. Relevance for the evaluation of 
genotoxicity questionable. 
Sister chromatid 
exchange 
Mouse spermatocytes Oral (gavage) 200, 400 or 800 
mg/kg bw 
Positive (Tian et al., 1992) 
 
Limited validity. Relevance for the 
evaluation of genotoxicity questionable; 
non-validated test protocol. 
Micronucleus 
formation 
Mouse early sperm 
cells 
Oral (gavage) 200, 400 or 800 
mg/kg bw 
Positive (Tian et al., 1992) 
 
Limited validity. Non-validated test 
protocol. 
Micronucleus 
formation 
Mouse peripheral 
blood cells 
Gavage 1000, 2000 
3000 mg/kg bw 
Positive (Hiramoto et al., 1998) 
 
Valid. 
Micronucleus 
formation 
Male mice peripheral 
erythrocytes 
I.p. 500, 1000, 1500 
mg/kg bw 
Positive (Hiramoto et al., 
1996b) 
 
Valid. 
2-ethyl-4-hydroxy-5-methyl-
3(2H)-furanone [13.084] 
Micronucleus 
formation 
Mouse peripheral 
blood cells 
Gavage 0, 1000, 2000, and 
3000 mg/kg bw  
Positive (Hiramoto et al., 1998) 
 
Valid. 
Micronucleus 
formation 
Male mice peripheral 
erythrocytes 
I.p. 0, 500 and 1000 
mg/kg bw 
Positive (Li et al., 1998) 
 
Valid. 
a: Validity of genotoxicity studies: 
 Valid. 
 Limited validity (e.g. if certain aspects are not in accordance with OECD guidelines or current standards and / or limited documentation). 
 Insufficient validity (e.g. if main aspects are not in accordance with any recognised guidelines (e.g. OECD) or current standards and/or inappropriate  test system). 
 Validity cannot be evaluated (e.g. insufficient documentation, short abstract only, too little experimental details provided). 
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Table 8:  Summary of Additional Genotoxicity Data on 4-hydroxy-2,5-dimethylfuran-3(2H)-one Submitted by Industry 
Summary of New Genotoxicity Data Submitted on Subgroup 4.4b (in vitro and in vivo) 
Chemical Name [FL-no]  Test System Test Object  Route Dose Reported Result  Reference  Comments a 
4-hydroxy-2,5-dimethylfuran-
3(2H)-one [13.010] 
Mouse Lymphoma L5178Ytk+/- 
mouse lymphoma 
cells 
- 111, 167, 250, 375 and 
750 micrograms/ml 
Negative both with and 
without S9 
(Ross and Harris, 1979a) limited validity.  
Study not performed according to 
current guideline. To short 
treatment and no differentiation 
between small and large colonies. 
 
Dominant Lethal 
assay in a rat fertility 
study 
Dominant lethals in 
Crl:CD(SD) male 
rats (25/group) 
Oral gavage 100, 500 and 1000 mg/kg 
bw/day for 2 
weeks(Phase I) and 9 
weeks (Phase II) 
No increase of dominant 
lethal effects 
(Sloter, 2008) Valid GLP study in accordance 
with ICH Guideline 4.1.1. 
A study by Honarvar (Honarvar, 2008) was also submitted. However due to unknown identity of the tested material, this study is not included in the table. 
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Table 9:  Summary of Additional Genotoxicity Data on 2,5-Dimethylfuran-3(2H)-one and 4-Acetyl-2,5-dimethylfuran-3(2H)-one Submitted by Industry 
Summary of New Genotoxicity Data Submitted on Subgroup 4.4a (in vitro) 
Chemical Name [FL-no]  Test System Test Object  Dose Reported Result  Reference  Comments  
2,5-Dimethylfuran-3(2H)-one 
[13.119] 
Reverse 
Mutation 
S. typhimurium TA98, 
TA100, TA102, TA1535 
and TA1537 
3 - 1000 μg/plate [1,2] Negative (Sokolowski, 2007) 
 
All strains were negative. Study design complied with current GLP 
and OECD recommendations. Acceptable top concentration was 
achieved. 
S. typhimurium TA98, 
TA100, TA102, TA1535 
and TA1537 
33 - 5000 μg/plate 
[1,3] 
Negative 
Micronucleus 
Assay 
Human peripheral blood 
lymphocytes 
900 - 1120 μg/mL 
[1,6] 
900 - 1120 μg/mL 
[4,7] 
Negative (Lloyd, 2011) The MNBN cell frequencies in all treated cultures fell within the 
normal range. Complies with draft OECD Guideline 487 and GLP 
recommendations. 
4-Acetyl-2,5-
dimethylfuran-3(2H)-one 
[13.175] 
Reverse 
Mutation 
S. typhimurium TA98, 
TA100, TA102, TA1535 
and TA1537 
0.32 - 5000 μg/plate 
[1,2] 
Negative (Bowen, 2011) Evidence of toxicity was observed at 5000 μg/plate in all strains in 
the absence and presence of S-9. Study design complied with 
current GLP and OECD recommendations. 
Micronucleus 
Assay 
Human peripheral blood 
lymphocytes 
1000 - 1542 μg/mL 
[1,6]  
400-950 μg/mL [1,7] 
Equivocal (Lloyd, 2012) Study in compliance with GLP and OECD recommendations. 
Statistical significant increase, dose-related, in the presence of S9-
mix at all three concentrations in a first experiment. Lower 
stastical significance at the two highest concentrations in an 
enlarged scoring, carried out with an unjustified approach. Mean 
MNBN cell frequencies fell within the historical control range with 
exception of a single replicate. 
 
[1] With and without S9 metabolic activation. 
[2] Plate incorporation method. 
[3] Pre-incubation method. 
[4] Without S9 metabolic activation. (not used). 
[5] With S9 metabolic activation.(not used). 
[6] 3-hour incubation with 21-hour recovery period. 
[7] 24-hour incubation with no recovery period. 
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ABBREVIATIONS 
ADI  Acceptable Daily Intake 
BW  Body Weight 
CAS  Chemical Abstract Service 
CEF Panel on Food Contact Materials, Enzymes, Flavourings and Processing Aids 
Chemical Abstract Service 
CHO  Chinese hamster ovary (cells) 
CHL  Chinese Hamster Lung (cells) 
CoE  Council of Europe 
DNA  Deoxyribonucleic acid 
EC             European Commission 
EFFA  European Flavour and Fragrance Association 
EFSA  The European Food Safety Authority 
EU  European Union 
FAO  Food and Agriculture Organization of the United Nations  
FEMA  Flavor and Extract Manufacturers Association 
FGE  Flavouring Group Evaluation  
FLAVIS (FL) Flavour Information System (database) 
GLP  Good Laboratory Practice 
ICH  International Conference on Harmonisation 
ID   Identity 
IOFI  International Organization of the Flavour Industry 
IR   Infrared spectroscopy 
JECFA  The Joint FAO/WHO Expert Committee on Food Additives 
LD50  Lethal Dose, 50%; Median lethal dose 
MS  Mass spectrometry 
MSDI  Maximised Survey-derived Daily Intake 
mTAMDI Modified Theoretical Added Maximum Daily Intake 
NAD  Nicotinamide Adenine Dinucleotide  
NADP  Nicotinamide Adenine Dinucleotide Phosphate 
No  Number 
NOAEL No Observed Adverse Effect Level 
NOEL  No Observed Effect Level 
NTP  National Toxicology Program 
OECD  Organisation for Economic Co-operation and Development 
QSAR  Quantitative Structure-Activity Relationship 
SCE  Sister Chromatid Exchange 
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SCF  Scientific Committee on Food 
SMART  Somatic Mutation and Recombination Test  
TAMDI Theoretical Added Maximum Daily Intake 
UDS  Unscheduled DNA Synthesis  
WHO  World Health Organisation  
 
